These data suggest that short-term melatonin treatment in vivo but not in vitro improved glucose uptake and insulin responsiveness of cardiomyocytes in obesity and insulin-resistance states. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.